High-throughput, Predictive, and Reproducible Models for Hepatic, Cardiovascular, and Renal Toxicity Studies
Abstract
Toxicologists are challenged by the lack of cell models that are physiologically relevant, reliable, and consistent between experiments. Here, we will discuss ATCC’s immortalized primary cells, which exhibit the growth and reproducibility of continuous cells, and the in vivo biologies of primary cells.
Download the presentation to learn more about our models for toxicology.
Download
Presenter
Sujoy Lahiri, PhD
Lead Scientist, R&D, ATCC
Sujoy Lahiri, PhD, is an R&D scientist in ATCC. He leads the primary cell division, working on advanced cellular models using primary cells as well as expansion of ATCC’s primary cell portfolio. Dr. Lahiri has extensive knowledge in the field of toxicology and drug metabolism.
Explore our featured products
HepatoXcell™ Pro Primary Human Hepatocytes
HepatoXcell™ Pro are Primary Human Hepatocytes, 7 day Plateable are derived from normal, healthy, human liver tissues.
Order now
HepatoXcell™ Eco Primary Human Hepatocytes
HepatoXcell™ Eco Primary Human Hepatocytes Suspension Cells are derived from normal, healthy, human liver tissues.
Order now
HepatoXcell™ Plus Primary Human Hepatocytes
HepatoXcell™ Plus are Primary Human Hepatocytes, 3 day Plateable are derived from normal, healthy, human liver tissues.
Order now
HepatoXcell™ Media
Maximize the viability and functionality of your HepatoXcell™ hepatocytes with specially formulated media.
Explore now
Primary cells
ATCC Primary Cell Solutions consist of quality cells, reagents matched and optimized to work with each cell type, and trustworthy protocols.
order primary cells
hTERT-immortalized cells
hTERT-immortalized cells combine the in vivo nature of primary cells with the traditional cell line's ability to survive continuously in vitro.
Browse hTERT-immortalized cells
